journal cover

Retention, dosing, tolerability and patient reported seizure outcome of Zonisamide as only add-on treatment under real-life conditions in adult patients with partial onset seizures: Results of the observational study ZOOM

Seizure : the Journal of the British Epilepsy Association

Jan 7, 2016

Hajo HamerEdgar Kockelmann

Abstract

Zonisamide is licensed for adjunctive therapy for partial-onset seizures with or without secondary generalisation in patients 6 years and older and as monotherapy for the treatment of partial seizures in adult patients with newly diagnosed epilepsy, and shows a favourable pharmacokineti...read more

Mentioned in this Paper

Study
Treatment Protocols
Observational Study
Anticonvulsants
Epilepsy
Drug Tolerance
Drug Retention
Myopathy
Polychemotherapy
Single Seizure
Paper Details
References

Retention, dosing, tolerability and patient reported seizure outcome of Zonisamide as only add-on treatment under real-life conditions in adult patients with partial onset seizures: Results of the observational study ZOOM

Seizure : the Journal of the British Epilepsy Association

Jan 7, 2016

Hajo HamerEdgar Kockelmann

PMID: 26735004

DOI: 10.1016/j.seizure.2015.12.001

Abstract

Zonisamide is licensed for adjunctive therapy for partial-onset seizures with or without secondary generalisation in patients 6 years and older and as monotherapy for the treatment of partial seizures in adult patients with newly diagnosed epilepsy, and shows a favourable pharmacokineti...read more

Mentioned in this Paper

Study
Treatment Protocols
Observational Study
Anticonvulsants
Epilepsy
Drug Tolerance
Drug Retention
Myopathy
Polychemotherapy
Single Seizure

Related Papers

Paper Details
References
/papers/retention-dosing-tolerability-and-patient/26735004